Guidelines for pre-clinical animal and cellular models of MuSK-myasthenia gravis.

Guidelines for pre-clinical animal and cellular models of MuSK-myasthenia gravis.

Muscle-specific tyrosine kinase (MuSK) autoantibodies are the hallmark of a form of myasthenia gravis (MG) that can challenge the neurologist and the experimentalist. The clinical disease can be difficult to treat effectively. MuSK autoantibodies affect the neuromuscular junction in several ways. Wh...

Volledige beschrijving

Bibliografische gegevens
Hoofdauteurs:	Phillips, W, Christadoss, P, Losen, M, Punga, A, Shigemoto, K, Verschuuren, J, Vincent, A
Formaat:	Journal article
Taal:	English
Gepubliceerd in:	Academic Press Inc. 2015

Gelijkaardige items

Myasthenia gravis with MuSK antibodies
door: Farrugia, M, et al.
Gepubliceerd in: (2005)

The role of muscle-specific tyrosine kinase (MuSK) and mystery of MuSK myasthenia gravis.
door: Koneczny, I, et al.
Gepubliceerd in: (2014)

The role of muscle-specific tyrosine kinase (MuSK) and mystery of MuSK myasthenia gravis
door: Koneczny, I, et al.
Gepubliceerd in: (2014)

Potential mechanisms in MuSK-myasthenia gravis
door: Koneczny, I
Gepubliceerd in: (2014)

MuSK-Myasthenia Gravis Unmasked by Hydroxychloroquine
door: Shalini Bhaskar, et al.
Gepubliceerd in: (2022-01-01)

Infantile Onset Myasthenia Gravis with MuSK Antibodies
door: J Gordon Millichap
Gepubliceerd in: (2006-08-01)

The prevalence of MuSK antibody positive myasthenia gravis worldwide
door: Vincent, A, et al.
Gepubliceerd in: (2006)

Detection and characterization of MuSK antibodies in seronegative myasthenia gravis.
door: McConville, J, et al.
Gepubliceerd in: (2004)

MuSK antibody-positive, seronegative myasthenia gravis in Korea.
door: Lee, J, et al.
Gepubliceerd in: (2006)

MuSK Antibody Positive Myasthenia Gravis Mimicking as Myositis
door: Nilesh Wagh, et al.
Gepubliceerd in: (2024-09-01)

MuSK-Associated Myasthenia Gravis: Clinical Features and Management
door: Carmelo Rodolico, et al.
Gepubliceerd in: (2020-07-01)

Patient-specific therapeutic benefit of MuSK agonist antibody ARGX-119 in MuSK myasthenia gravis passive transfer models
door: Jamie L. Lim, et al.
Gepubliceerd in: (2025-02-01)

MuSK-antibody-positive myasthenia gravis in a South Asian population.
door: Chang, T, et al.
Gepubliceerd in: (2009)

Anti-MuSK antibodies in a case of ocular myasthenia gravis.
door: Bennett, D, et al.
Gepubliceerd in: (2006)

Anti-MuSK antibody positive myasthenia gravis with childhood onset
door: Diana Epure, et al.
Gepubliceerd in: (2016-06-01)

Progress in rituximab for anti⁃MuSK antibody-related myasthenia gravis
door: Ting LI, et al.
Gepubliceerd in: (2020-01-01)

Clinical Characteristics of MuSK Antibody-positive Myasthenia Gravis in Taiwan
door: Yung-Chuan Huang, et al.
Gepubliceerd in: (2008-07-01)

Anti-MuSK antibodies in seronegative myasthenia gravis: a cause of denervation
door: Newsom-Davis, J, et al.
Gepubliceerd in: (2001)

Strong association of MuSK antibody-positive myasthenia gravis and HLA-DR14-DQ5.
door: Niks, E, et al.
Gepubliceerd in: (2006)

Low frequency of MuSK antibody in generalized seronegative myasthenia gravis among Chinese.
door: Yeh, J, et al.
Gepubliceerd in: (2004)

Targeted treatment approaches and pathogenicity of antibody subclasses in MuSK-myasthenia gravis
door: Cao, M
Gepubliceerd in: (2021)

Efgartigimod treatment in patients with anti-MuSK-positive myasthenia gravis in exacerbation
door: Fangyi Shi, et al.
Gepubliceerd in: (2024-11-01)

Coexistence of anti-MuSK antibody-positive myasthenia gravis and rheumatoid arthritis
door: Amber Eker, et al.
Gepubliceerd in: (2020-08-01)

Regional Features of MuSK Antibody-Positive Myasthenia Gravis in Northeast China
door: Zunwei Zhang, et al.
Gepubliceerd in: (2020-10-01)

Acetylcholine receptors loss and postsynaptic damage in MuSK antibody-positive myasthenia gravis.
door: Shiraishi, H, et al.
Gepubliceerd in: (2005)

Myasthenia Crisis as First Presentation of MuSk Positive Myasthenia Gravis: A Case Report
door: Dipesh Chhetri, et al.
Gepubliceerd in: (2025-02-01)

Compromised fidelity of B-cell tolerance checkpoints in AChR and MuSK myasthenia gravis
door: Lee, J, et al.
Gepubliceerd in: (2016)

Anti-MuSK-Positive Myasthenia Gravis in a Patient with Parkinsonism and Cognitive Impairment
door: S. Lanfranconi, et al.
Gepubliceerd in: (2011-01-01)

MuSK Myasthenia Gravis—Potential Pathomechanisms and Treatment Directed against Specific Targets
door: Edyta Dziadkowiak, et al.
Gepubliceerd in: (2024-03-01)

Bortezomib in severe MuSK-antibody positive myasthenia gravis: first clinical experience
door: Christiane Schneider-Gold, et al.
Gepubliceerd in: (2017-10-01)

Quantitative EMG studies to assess facial muscle atrophy in MuSK antibody positive myasthenia gravis
door: Farrugia, M, et al.
Gepubliceerd in: (2007)

Immunotherapies in MuSK-positive Myasthenia Gravis; an IgG4 antibody-mediated disease
door: Aigli G. Vakrakou, et al.
Gepubliceerd in: (2023-07-01)

Differential Cytokine Changes in Patients with Myasthenia Gravis with Antibodies against AChR and MuSK.
door: Vuslat Yilmaz, et al.
Gepubliceerd in: (2015-01-01)

Anti-MuSK antibody positive myasthenia gravis with Graves disease: one case report
door: Shan CAO, et al.
Gepubliceerd in: (2019-02-01)

MuSK Myasthenia Gravis in an HIV-infected Chinese old man successfully treated with pyridostigmine
door: Yirui Xie, et al.
Gepubliceerd in: (2020-09-01)

Clinical comparison of anti-MuSK- vs anti-AChR-positive and seronegative myasthenia gravis.
door: Deymeer, F, et al.
Gepubliceerd in: (2007)

MRI and clinical studies of facial and bulbar muscle involvement in MuSK antibody-associated myasthenia gravis.
door: Farrugia, M, et al.
Gepubliceerd in: (2006)

Clinical fluctuations in MuSK myasthenia gravis are related to antigen-specific IgG4 instead of IgG1.
door: Niks, E, et al.
Gepubliceerd in: (2008)

A retrospective multicenter study on clinical and serological parameters in patients with MuSK myasthenia gravis with and without general immunosuppression
door: Koneczny, I, et al.
Gepubliceerd in: (2024)

Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies.
door: Hoch, W, et al.
Gepubliceerd in: (2001)